Pharma Billionaire’s Tactics Come Under Scrutiny As Opioid Crisis Rages On
Insys Therapeutics' co-founder John N. Kapoor is facing accusations from prosecutors that the company bribed doctors to prescribe large, off-label doses of its painkiller.
The independent source for health policy research, polling, and news.
35,381 - 35,400 of 112,565 Results
Insys Therapeutics' co-founder John N. Kapoor is facing accusations from prosecutors that the company bribed doctors to prescribe large, off-label doses of its painkiller.
Although President-elect Donald Trump promised during the campaign to not cut Medicare, his transition website and congressional Republicans now signal interest in making changes in the program. Details are not yet clear, but the intent is raising concerns.
Prescription drug costs are a big part of the reason, an analysis finds.
The state's "high-risk pool" approach could serve as a model to Republicans who want to dismantle the health law but retain the popular provision that no one can be denied coverage for pre-existing conditions.
Georgia Rep. Tom Price was one of the first to put forward his own replacement plan in proposed legislation.
While Indiana was one of few red states to adopt the health law's expansion, it added a requirement that many low-income residents help contribute financially to their health coverage. Meanwhile, other Republican-led states are watching closely to see how Washington wants to change the Medicaid system.
The conservative think tank lays out a "repeal and replace" plan that would roll back the ACA's rules around plans' age rating, essential benefits and actuarial value limits. Its experts also say Republicans should institute "sensible rules" to maintain protections for patients with pre-existing conditions but prevent those patients from gaming the system.
NOTE TO READERS: KHN's First Edition will not be published Nov. 24-25. Look for it again in your inbox Nov. 28. Here's today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Outlets report on health news from New Hampshire, Illinois, Tennessee, Georgia, Kansas, California, Missouri, Minnesota, New Jersey, Florida and Michigan.
Today's other public health stories cover diabetes complications, doctors grocery shopping with patients, misleading "aloe vera" products and bad exercise habits causing injury.
Elsewhere, communities around the country increasingly focus on reducing emergency room use by people with mental illness. And a Minnesota mental health task force issues recommendations to expedite care.
The technology uses wing beats to identify mosquito varieties. In other Zika news, Florida confirms 11 new cases.
Bodies that by all indications shut down because of overdoses can show nothing on drug screens. Forensic pathologists' jobs are further complicated by the fact that they often have little information about how much of a drug was consumed or how soon before death.
More than a million people don't have dementia who would have had it if the rates had stayed the same as 2000 rates, even though scientists expected a surge as the baby boomers age.
The warning notes that the implant may puncture the fallopian tubes and uterus and travel into the abdomen and pelvic cavity, causing persistent pain and requiring surgical removal.
Meanwhile, the agency is punting a decision to Congress and the incoming administration over how to regulate certain medical tests.
Mylan says it is refusing the committee's request because of the pending settlement and no one from CMS or the Justice Department will be attending.
The much-anticipated and closely watched trial over Anthem's acquisition of Cigna kicked off on Monday.
The House Democratic leader pledges to fight any GOP efforts to overhaul the health program that serves older Americans. In other news: a look at how Republicans might cut Medicare funding as part of efforts by President-elect Donald Trump's "trillion-dollar" agenda, and congressional Democrats are lobbying the administration to drop a plan to change how Medicare pays for some prescription drugs.
© 2026 KFF